Aim: This review aims to provide an up-to-date overview of pharmacological studies of Tithonia diversifolia (Hemsl.) A.Gray. Moreover, the focus of this review is the possible exploitation of this species to treat different diseases and to suggest future investigations.
Mexico, Nicaragua, Panama, the United States, Zanzibar, and exotic in India, Kenya, Philippines. This shrub is an important medicinal plant whose leaf is the major plants part used alone or in combination with other plants for the treatment of a wide variety of ailments, such as stomach pains, indigestion, sore throat, liver diseases, and pain. This is because the leaf is considered to have most of the active constituents. 2 It has been reported to possess antiplasmodial activity 3 and testified to have the presence of sesquiterpene lactones as well as an artemisinin acid analog from T. diversifolia. 4, 5 It also possesses antiinflammatory and analgesic properties; 6 have resistance against bile, kidney, urinary and venereal diseases, testicular inflammation, frigidity, sterility, heavy menstruation, rheumatism and arthritis, upper respiratory tract infections ranging from cough to tuberculosis, intestinal worms and schistosomiasis, cancer chemopreventive activity; 7 cytotoxic properties, 8, 9 and antimicrobial activity. 10, 11 This plant is a weed that grows quickly and has become an option as an affordable alternative to expensive synthetic fertilizers. It has shown to increase plant yields and the soil nutrients of nitrogen, phosphorus, and potassium. 12 Tithonia diversifolia has been a subject of research interest because of its various indigenous medicinal uses in many countries.
RESULTS

Botanical Description
Tithonia diversifolia is a woody herb or succulent shrub, 1.2 to 3 m tall, with opposite leaves (3-5), attenuate base, acute apex, and crenate margin. Leaf size is 5 to 17 × 5 to 12 cm, densely pubescent beneath with palmate venation. Occasionally, upper leaves are unloaded. Flowers are yellow, their ray size is 306 cm × 5 to 18 mm. The flower heads are solitary on a peduncle, 6 to 13 cm long. Each mature stem may bear several flowers at the top of branches. The plant flowers and produces seeds throughout the year. The light-weight seeds can be dispersed by wind, water, and animals.
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PHARMACOLOGICAL STUDIES
Antibacterial Activity
The medicinal properties of the aqueous leaves extract of T. diversifolia were evaluated in vitro by antimicrobial and antifungal assays and it showed growth inhibitory effects on Staphylococcus aureus and Escherichia coli, but Pseudomonas aeruginosa and Saccharomyces cerevisiae were resistant to all the plant extracts and the antibiotic controls. The minimum inhibitory concentrations of the aqueous extract of T. diversifolia on S. aureus and E. coli were both 12.50 mg. The minimum bacterial concentration of the aqueous extract against the test organism ranged from 12.50 to 25.00 mg.
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Antioxidant Activity
The evaluation of the antioxidant activity was assessed by the sequestrant ability of extracts on free radical 2,2-diphenyl-1-picrylhidrazila (DPPH). A methanol solution of DPPH at the concentration of 40 mg/mL was prepared where the aqueous and ethanolic crude extracts of T. diversifolia were diluted in methanol at the following concentrations (5-2, 5-1, 0-0, 75-0.5, and 0.25 mg/mL). A strong antioxidant activity of both the aqueous ethanol extracts was observed as ethanol dose dependent on the type DPPH with IC 50 of 2.273 and 0.630 mg/mL respectively, for aqueous crude extract and crude extract ethanol, and it was found that the plant species is a promising source of antioxidant compounds. 
Anti-inflammatory Activity
Aqueous leaf extract of T. diversifolia at a dose of 400 mg/ kg exhibited significant anti-inflammatory activity in carrageenan-induced rat paw edema model. The mean percentage inhibition of paw volume was highest in rats to which indomethacin was administered (85.65%), followed by the rats administered aspirin (68.40%) which was comparable to that of rats given T. diversifolia (63.79%). Indomethacin caused the highest inhibition of paw edema, followed by inhibition caused by aspirin and that caused by T. diversifolia extract.
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Antinociception Activity
Aqueous leaf extract of T. diversifolia at a dose of 400 mg/ kg exhibited significant antinociceptive activity in mice. The group dosed with morphine had the highest reaction time of 31.81 ± 1.50 s 
Acute Toxicity Test
Oral administration of T. diversifolia leaves' aqueous extract to rats up to 10000 mg/kg caused no death in the two phases of the test after 24 hours. The LD 50 of T. diversifolia extract in rats was estimated to be greater than 10000 mg/kg.
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Antidiarrheal Activity
The antidiarrheal effect of aqueous extract of T. diversifolia leaves (200, 400, and 800 mg/kg doses) was studied using castor-oil-induced-diarrhea model (dropping test), castor-oil-induced enteropooling (secretory test), and gastrointestinal transit test (charcoal transit) in rats. The results showed that T. diversifolia leaves' aqueous extract reduced wet fecal output in castor-oil-induced diarrhea but with slightly greater frequencies in comparison with loperamide-treated animals and had less volume of intestinal contents as compared with the negative control (distilled-water-treated animals). It also had a significant (p < 0.05) nondose-dependent reduction in speed and distance traveled by charcoal in gastrointestinal tract but slightly higher speed and longer distance than the atropine-treated rats. Aqueous extract was found to have remarkable antidiarrheal effect in castor-oil-induced diarrhea, enteropooling, and gastrointestinal motility models attesting to its utility in a wide range of diarrheal states traditionally.
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Antimalarial Activity
Comparison of the effectiveness of Chloroquine with the aqueous and methanolic extracts of T. diversifolia showed that Chloroquine was 100% effective in clearing the parasite, while the aqueous and methanolic extracts were 50 and 74% effective in clearing the parasites respectively. Both aqueous and methanolic extracts were more effective when administered before the onset of the infection, probably indicating the time-dependency of the antimalarial effects. Earlier application of the extracts at the onset of the malaria symptoms was more effective in reducing the parasitemia within a few days. The administration of the plant extracts during the malaria episode was also effective with longer period of administration. The LC 50 of the aqueous extract in mice was 1.2 mL/100 gm body weight (BW), while the maximum tolerated dose was found to be 1.0 mL/gm. 18 The antimalarial properties of T. diversifolia were investigated in vitro against three strains of Plasmodium falciparum. The ether extract from aerial parts of the plant JDRAS demonstrated good antiplasmodial activity (IC 50 on plasmodium falciparum chloroquine sensitive strain: 0.75 µg/mL). A bioassay-guided fractionation of the extract led to the isolation of the known sesquiterpene lactone tagitinin C as an active component against Plasmodium (IC 50 on plasmodium falciparum chloroquine sensitive strain: 0.33 µg/mL).
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Antihyperglycemic Activity
The antihyperglycemic activity of aqueous leaf extracts of T. diversifolia at dose of 500 mg/kg BW was studied by oral glucose tolerance test (OGTT) in normal mice and was administrated daily orally in alloxan-induced diabetic mice for 4 weeks. Hypoglycemic effect of T. diversifolia at dose of 500 mg/kg BW showed significantly reduced blood glucose level on OGTT in normal mice (p < 0.05). Moreover, the plant-extract-treated alloxan-induced diabetes mice for 30 days significantly decreased blood levels of glucose, total cholesterol, triglyceride, and low-density lipoprotein cholesterol and increased high-density lipoprotein cholesterol.
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Cancer Chemopreventive Activity Activity-guided fractionation of an ethyl acetate extract of the aerial parts of T. diversifolia, using an antiproliferation bioassay performed with human colon cancer (Col2) cells, led to the isolation of three new sesquiterpenoids, 2-alpha-hydroxytirotundin, tithofolinolide, and 3-alpha-acetoxydiversifolol, along with eight known sesquiterpene lactones, 3-beta-acetoxy-8-beta-isobutyryloxyreynosin, tagitinin C, 1-beta-2-alpha-epoxytagitinin C, 4-alpha-10-alpha-dihydroxy-3-oxo-8-beta isobutyryloxyguaia-11(13)-en-12,6-alpha-olide, 3-alpha-acetoxy4alpha-hydroxy-11(13)-eudesmen-12-oic acid methyl ester, 17,20-dihydroxygeranylnerol, tagitinin A, and tirotundin. These isolates were evaluated for their potential as cancer chemopreventive agents by measuring their antiproliferative activity in Col2 cells and induction of cellular differentiation in human promyelocytic leukemia (HL-60) cells. Selected compounds were investigated for their ability to inhibit 7,12-dimethylbenz [a] anthracene-induced preneoplastic lesions in a mouse mammary organ culture assay. Among these isolates, tagitinin C and 1-beta-2-alpha-epoxytagitinin C showed significant antiproliferative activity, tithofolinolide, 3-beta-acetoxy-8-beta-isobutyryloxyreynosin, and 4-alpha,10-alpha-dihydroxy-3-oxo-8beta-isobutyryloxyguaia-11(13)-en-12,6-alpha-olide induced HL-60 cellular differentiation, and 43-beta-acetoxy-8-beta-isobutyryloxyreynosin significantly inhibited (63.0% at 10 µg/mL) lesion formation in the mouse mammary organ culture assay.
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DISCUSSION
An extensive and systematic review of the extant literature was carried out, and electronic search on worldwide accepted scientific databases (Science Direct, PubMed, and Google Scholar) was performed to compile the relevant information. All abstracts and full-text articles were examined. The most relevant articles were selected for screening and inclusion in this review. Tithonia diversifolia has been reported to possess a number of medicinal properties being used traditionally and has been commonly used for diverse medicinal purpose in many countries of the world. From the above review results, it has been observed that T. diversifolia has various therapeutic actions, such as anti-inflammatory, analgesic, antinociception, antimalarial, antibacterial, antitumor, antidiabetic, antidiarrheal, and antihelminthic activity.
CONCLUSION
The plant extracts and their active constituents should be subjected to more detailed mechanistic studies, in vivo investigations in various animal models, and hence, further studies has to be taken up to identify and isolate new compounds or particular compounds for the development of new drugs including pharmacokinetic and bioavailability studies to fully understand the mode of action of the different active constituents and also to prove and scientifically validate for its different therapeutic actions, such as anti-inflammatory, analgesic, antinociception, antimalarial, antibacterial, antitumor, antidiabetic and antidiarrheal activity.
Clinical Significance
Till date, there is no scientific literature/data regarding clinical trials of this plant except preclinical studies on different laboratory animals.
